Skip to main content

Table 2 Predictors of survival of hospitalized children with COVID-19, Mexico 2020–2021

From: Decreased survival in children inpatients with COVID-19 and antibiotic prescription

Characteristic HR (95% CI),\(p\)
Bivariate analysis Multiple analysis
Sex     
 Girl 1.00   1.00  
 Boy 0.84 (0.61–1.16) 0.301 0.82 (0.59–1.13) 0.227
Age group (years)     
 < 1 1.00   1.00  
 1–4 0.96 (0.67–1.39) 0.836 0.97 (0.67–1.41) 0.883
 5–9 1.11 (0.74–1.67) 0.617 1.13 (0.75–1.71) 0.556
Date of symptoms onset     
 March 2020–April 2021 1.00   1.00  
 May 2021–December 2021 0.86 (0.60–1.23) 0.401 0.88 (0.61–1.27) 0.504
Days from symptoms onset to healthcare-seeking 1.06 (1.01–1.11) 0.015 1.05 (1.01–1.10) 0.040
Antibiotic (any) was prescribed at hospital admission     
 No 1.00   1.00  
 Yes 1.82 (1.25–2.66) 0.002 1.50 (1.01–2.22) 0.043
Pneumonia diagnosis at hospital admission     
 No 1.00   1.00  
 Yes 2.15 (1.53–3.03)  < 0.001 1.94 (1.37–2.77)  < 0.001
Cardiovascular disease     
 No     
 Yes 2.04 (0.94–4.44) 0.073 1.90 (0.87–4.14) 0.106
  1. (1) Generalized linear regression models were used to obtain the presented estimates; (2) HR and 95% CI from the multiple analysis were adjusted by the variables presented in the table
  2. COVID-19 Coronavirus disease 2019; HR hazard ratio; CI confidence interval